PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 1, 1973The Journal of Infectious Diseases36 citations

Pseudomonas cepacia Tricuspid Endocarditis: Treatment with Trimethoprim, Sulfonamide, and Polymyxin B

View Full Paper
JRJames J. RahalMSMichael S. SimberkoffPHPhineas J. Hyams

Key Points

Key points are not available for this paper at this time.

Abstract

Tricuspid endocarditis due to Pseudomonas cepacia in a heroin addict persisted despite intensive antibiotic therapy as well as replacement of the infected valve on four occasions. The isolated organism and 10 other strains of Pseudomonas cepacia were resistant to all antibiotics except chloramphenicol and trimethoprim (TMP), to which moderate sensitivity was demonstrated. Addition of TMP or both TMP and sulfonamide to polymyxin B produced sensitivity to low concentrations of the latter drug in vitro. Treatment with polymyxin B and TMP (1,000 mg/day) yielded bactericidal activity in serum at a 1:4 dilution. The combination of polymyxin B, TMP, and sulfisoxazole is effective and bactericidal against Pseudomonas cepacia in vitro and deserves further clinical trial in the treatment of serious infection due to this organism.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rahal et al. (1973) studied this question.

synapsesocial.com/papers/6a8999df991508d05dc98fe3https://doi.org/10.1093/infdis/128.supplement_3.s762
Ask AI
Helpful
Bookmark
Share
View Full Paper